Inactive Instrument

Highlights Roche Holding AG Xetra

Equities

Swiss Equities Advance as Cool US Inflation Data Boosts Sentiment	05:32pm	MT
Wegovy weight loss sustained for four years in trial, Novo Nordisk says	05-14	RE
Lonza Affirms FY24 Sales Outlook, Raises Mid-term Growth Guidance	05-14	MT
Xbrane Biopharma, Stada Sign US Licensing Deal for Lucentis Biosimilar	05-10	MT
Enable Injections, Inc. Announces Collaboration with Roche to Develop and Commercialize Combination of the enFuse Technology with Specific Roche Development Programs	05-07	CI
Swiss Equities Close in Red Amid Inflation Spotlight	04-29	MT
Roche Holding AG: slimming down	04-29
European Medicines Agency Committee Backs Roche's Subcutaneous Injection for Multiple Sclerosis	04-29	MT
Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU	04-26	MT
The specter of stagflation rears its ugly head again	04-25
ROCHE : Barclays lowers target price	04-25	CF
Scholz pledges further support for the pharmaceutical industry	04-25	DP
Scholz promises support for pharma sector in Germany as Merck invests	04-25	RE
Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5%	04-25	MT
Health Care Down Amid Mixed Earnings -- Health Care Roundup	04-24	DJ
Roche’s Downbeat Q1 Sales Drag Swiss Market Index to Red	04-24	MT
ROCHE HOLDING : In line quarterly results won’t cut it for Roche	04-24
Global markets live: Heineken, AT&T Hasbro, Visa, Boeing...	04-24
Biogen beats quarterly profit estimates, Alzheimer's drug sales jump	04-24	RE
Roche Eyes Potential M&A Deals Amid Pipeline Restructure	04-24	MT